APA (7th ed.) Citation

Kimura, S., Katsuya, H., Nakashima, C., Sueoka-Aragane, N., Hayashida, K., Sasaki, K., . . . Kimura, S. (2025). Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic. BMC Immunology, 26(1), 1. https://doi.org/10.1186/s12865-025-00711-w

Chicago Style (17th ed.) Citation

Kimura, Sakiko, et al. "Incidence of Severe Adverse Events in Cancer Patients After Treatment with Immune-checkpoint Inhibitors During the COVID- 19 Pandemic." BMC Immunology 26, no. 1 (2025): 1. https://doi.org/10.1186/s12865-025-00711-w.

MLA (9th ed.) Citation

Kimura, Sakiko, et al. "Incidence of Severe Adverse Events in Cancer Patients After Treatment with Immune-checkpoint Inhibitors During the COVID- 19 Pandemic." BMC Immunology, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s12865-025-00711-w.